The UK's health regulator on Tuesday approved Moderna's COVID-19 vaccine for use in children aged 12 to 17 years, weeks after Pfizer's shot was given the green light for deployment ahead of schools reopening.
The Medicines and Healthcare products Regulatory Agency (MHRA) has confirmed the vaccine, known as Spikevax, is safe and effective in this age group, it said, according to the Reuters news agency.
Read more